In today’s briefing:
- India: AMFI Stock Reclassification Preview
- Infomedia Draws in Vista Equity Partners to Start a Three-Way Auction
- Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions
India: AMFI Stock Reclassification Preview
- Nearing the end of the review period, we see 5 stocks moving from MidCap to LargeCap, 2 new listings added to LargeCap and 7 stocks moving from LargeCap to MidCap.
- We see 7 stocks moving from SmallCap to MidCap, 3 new listings added to MidCap, and 12 stocks moving from MidCap to SmallCap.
- Stock migrating upward have, on average, outperformed stocks that are downward migrations. Stocks moving from MidCap to LargeCap have performed the best.
Infomedia Draws in Vista Equity Partners to Start a Three-Way Auction
- Infomedia Ltd (IFM AU) disclosed an indicative non-binding proposal from Vista Equity Partners at A$1.70 a share. The Board has provided due diligence to all three bidders
- Curiously, Vista’s offer is in line with TA/Viburnum but below the Battery Ventures’ offer of A$1.75. This suggests that Vista requires due diligence to firm up a higher bid.
- With the market downturn starting to blow up M&A deals, the three-way auction for Infomedia lowers its risk profile. At last close, the gross spread to the offers is 6.3-9.4%.
Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions
- Lunit is getting ready to complete its IPO in Korea in July. The IPO base deal size is from $42 million to $46 million.
- Established in 2013, Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.
- Lunit is a pioneer in the medical artificial intelligence industry. The company has developed and commercialized AI-assisted detection solutions that complement human visual limitations through deep learning technology.
Before it’s here, it’s on Smartkarma
